tuberculosis (MDR-TB) is an increasing global problem. Good laboratory diagnosis
is key to prompt treatment. This study aimed at assessing the laboratory performance
in the multidrug-resistant tuberculosis (MDR-TB) control activities in Kano state,
north west Nigeria, 2018.
We reviewed data and used
a check list for assessment and analysis of secondary data of Kano state DR TB component
of the state tuberculosis and leprosy control programme (STBLCP). The data was analyzed
using Epi Info version 3.5.4 and Microsoft Excel 2007.
state in 2018 had a total of 37496 presumptive Mycobacterium tuberculosis (MTB)
cases reported and 37496 (100%) tested. Of the 37496 presumptive MTB cases tested,
36641 (97.7%) were presumptive pulmonary MTB cases and 855 (2.3%) were presumptive
extra pulmonary MTB cases. Of the 37496 tested, 33781 (90.1%) were MTB negative,
3715 (9.9%) MTB positive. Of the 3715 MTB positive cases, 3531 (95.0%) were MTB
positive but drug sensitive (DS MTB), 140 (3.8 %) were MDR TB cases and 44 (1.2%)
were indeterminate. Of the 140 MDR TB cases, 3 (2.1%) were <15 years of age,
137 (97.9%) were ≥15 years age, 101 (72.1%)
were males and 39 (27.8%) were females.
laboratory performance of Kano state MDR-TB control programme activities is good
with good detection rate and 100% testing rate. There is high number of MDR TB cases.
Majority of MDR TB cases are males and aged ≥15 years of age. There is need for the state TBLCP and partners to
intensify community awareness on MDR TB
Assessment, laboratory performance,
Multidrug-resistant tuberculosis, Kano state, north west Nigeria.
. National action plan for combating multidrug-resistant tuberculosis. The White House Washington. Accessed on 24/10/19 from https://www.usaid.gov/what-we-do/global-health/tuberculosis/national-action-plan-combating-mdr-tb.
. World Health Organization Global Tuberculosis Report 2015: http://www.who.int/tb/publications/global_report/en/.
of MDR-TB: A Field Guide: A Companion Document to Guidelines for Programmatic Management
of Drug-Resistant Tuberculosis: Integrated Management of Adolescent and Adult Illness
(IMAI). WHO Guidelines Approved by the Guidelines Review Committee. Geneva: World
Health Organization; 2009. Accessed on 19/10/19 from URL: https://www.ncbi.nlm.nih.gov/pubmed/26290923.
Factsheet on Tuberculosis: http://www.cdc.gov/tb/publications/infographic/pdf/take-on-tuberculosis-infographic.pdf
updated to 2014 dollars from Treatment Practices, Outcomes, and Costs of Multidrug-Resistant
and Extensively drug-Resistant Tuberculosis, United States, 2005–2007, S. M.
Marks, et al., Emerging Infectious Disease Journal (2014).
LE, Vassin MA, Al-Sonboli, Lawson N, B Ahader J (2011) A multi-country non-inferioriy
cluster randomize trial of front–loaded smear microscopy for the diagnosis of pulmonary
tuberculosis. PLOS Med 8: l000403.
S, Pal N, Malhotra B, Goyal S, Kumar V (2011) Comparison of Ziehl- Neelsen and Auramine
staining methods on direct and concentrated.
AA (2011) Gene Xpert: A game changer for tuberculosis control? PLOS Medicine.
Y, Heym B, Allen B et al. (1992) The catalase-peroxidase gene and isoniazid
resistance in M.tuberculosis. Nature, 358, 591–3.
AS, Telenti A, Murray MR et al. (2000) Genetotypic analysis of Mycobacterium
tuberculosis in two distinct populations using molecular beacons: implications
for rapid susceptibility testing. Antimicob Agents Chemother, 44,
A, Imboden P, Marchesi F et al. (1993) Detection of rifampicin resistance
mutations in Mycobacterium tuberculosis. Lancet, 341, 647–50.
FA, Pozniak AL. (1996) Molecular diagnosis, detection of drug resistance and epidemiology
of tuberculosis. Br J Hosp Med, 56, 204–8.
World Gazetteer. Profile of Kano, the capital city of State. Archived from the original
on 9 February2013. Retrieved 2007-03-27. Accessed on 07/10/2019 from URL:http://www.http/kano/profile.
Nigeria (2017). National Bureau of statistics: demographic statistics bulletin.
Accessed on 22/10/19 from URL: https://nigerianstat.gov.ng
B, Erturan S, Sonmez Duman E, Ongen G. Comparison of extra-pulmonary and pulmonary
tuberculosis cases: factors influencing the site of reactivation. Int J Tuberc Lung
Dis. 2005; 9:1220–3. [PubMed] [Google Scholar].
Thoracic Society Diagnostic standards and classification of tuberculosis in adults
and children. Am J Respir Crit Care Med. 2000; 161:1376–95. [PubMed] [Google Scholar].
JP, Lo YR. Epidemiology of HIV-TB in Asia. Indian J Med Res. 2004; 120:277–89. [PubMed]
SS, Kumarasamy N, Celentano DD, Yepthomi TH, Arvind VP, Solomon S. Trends in HIV-related
morbidity among patients admitted to a South Indian tertiary hospital between 1997
and 2003. AIDS Care. 2006; 18:366–70. doi: 10.1080/09540120500201755. [PubMed] [CrossRef]
CT, Panduru KV, Verma SC, Joshi
HS, Bates MN. 2008. omparison of pulmonary
and extrapulmonary tuberculosis in Nepal- a hospital-based retrospective study.
BMC Infect Dis. 2008; 8: 8.
D, Elutayo O, Olanrewaju O, Olapade GD. Pre-extensive drug resistant TB among MDR-TB
patients. Global Advd Res J Microbiol. 2013; 2:22–5. [Google Scholar].
L, Yassin MA, Abdurrahman ST, Parry CM, Dacombe R, Sogaolu OM, et al. Resistance
to first-line tuberculosis drugs in three cities of Nigeria. Trop Med Int Health.
2011; 16:974–80. [PubMed] [Google Scholar].